The Guadian's Denis Campbell reports that trial results suggest people with newly diagnosed glioblastoma could potentially be given extra years of life. A senior NHS doctor, Prof Keyoumars Ashkanwho, was one of the trial’s chief investigators said the evidence showed DCVax had resulted in “astonishing” enhanced survival for patients.Overall 13% of people who received it lived for at least five years after diagnosis. The vaccine is a form of immunotherapy, in which the body’s immune system is programmed to track down and attack the tumour. It is the first developed to tackle brain tumours. https://www.theguardian.com/science/2022/nov/17/vaccine-shown-to-prolong-life-pat
Cancer patients are testing a drug made from antibodies designed from the ground up on a computer in Israel and “programmed” by the inventor to “decide” whether cells surrounding tumors are good or bad. If the study underway in Australia goes according to plan, these antibodies will target cells that help the tumor while boosting the abilities of cells that inhibit cancer growth. Their inventor, Prof. Yanay Ofran, said that antibody treatments have traditionally been based on human or animal antibodies... making antibodies from scratch on a computer and then making them from amino acids removes previous limitations... https://israeltrade.org.au/2022/11/23/australian-cancer-patients-te